Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 206-735-5 | CAS number: 371-40-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Neither guideline nor GLP compliant study but nevertheless well documented and scientifically acceptable.
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 003
Materials and methods
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- The test method is according to a neurotoxicity test. Based on a preliminary study a TDL0 of 600 mg/kg bw was determined which was used as application dose.
- GLP compliance:
- not specified
- Test type:
- fixed dose procedure
Test material
- Reference substance name:
- 4-fluoroaniline
- EC Number:
- 206-735-5
- EC Name:
- 4-fluoroaniline
- Cas Number:
- 371-40-4
- Molecular formula:
- C6H6FN
- IUPAC Name:
- 4-fluoroaniline
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Crj: CD(SD)
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: 4 weeks
- Housing: Polycarbonate cages (three rats per cage)
- Diet: standard laboratory diet (MF, Oriental Yeast Co., Ltd, Tokyo, Japan)
- Water: ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature: 20-24 °C
- Humidity: 40-70%
- Photoperiod: 12-h light/dark
Administration / exposure
- Route of administration:
- oral: unspecified
- Vehicle:
- olive oil
- Doses:
- 600 mg/kg bw
- No. of animals per sex per dose:
- 9 (males)
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 15 days
- Frequency of observations and weighing: All rats were carefully observed for mortality and clinical signs at 30 min and 5 h after dosing and once a day thereafter for the following 15 days. Body weights were recorded before dosing and on days 2, 4, 8, 15 and 16.
- Necropsy of survivors performed: Yes
- Other examinations performed:
- clinical signs:
Detailed clinical observations with functional tests were conducted on all rats 2 days before dosing and on day 9, and on all the surviving rats on day 15.
The observer first recorded each rat’s posture in the home cage, along with palpebral closure and the presence or absence of circling, writhing, biting, convulsions or vocalizations. Then the observer removed the rat, rating the ease of removal and handling, and recorded such signs as exophthalmos, crustiness around the eyes and piloerection. Extensor thrust, palpebral closure, fur appearance, lacrimation and salivation also were rated. The rat was placed on a field covered with a clean polypad. The rat was observed for 2 min and gait characteristics, arousal level and the number of supported or unsupported rearing and grooming episodes were recorded. At the end of 2 min, the number of faecal boluses and pools of urine on the field were recorded. Then the following reflex tests were carried out and recorded: approach response, touch response, finger-snap response, tail-pinch response, surface righting reflex and aerial righting reflex. Grip strength for fore- and hindlimbs was measured by a grip strength apparatus (Muromachi Kikai Co., Tokyo, Japan) and the mean value of two trials for each rat was recorded. Finally, the pads of the hind feet were painted with Indian ink and the rat was held in a horizontal position at a height of ca. 30 cm before being dropped onto paper. The distance between ink blots was measured and the mean value of two trials for each rat was recorded.
- histopathology:
Three rats from each experimental group were killed in numerical order on day 10 and the other rats were killed on day 16, under deep anaesthesia by an intraperitoneal injection of sodium pentobarbital. After cardiac perfusionfixation with a phosphate buffer solution containing paraformaldehyde (4%), glutaraldehyde (1%) and heparin (1000 IU/ L), the following organs and tissues were collected and fixed in 10% neutral buffered formalin solution: forebrain, including cerebral cortex, basal ganglia and corpus callosum; midbrain, including hippocampus, thalamus and hypothalamus; mesencephalon, including substantia nigria, colliculi, tectum and tegmentum; hindbrain, including cerebellum, pons and medulla oblongata; spinal cords, including cervical, thoracic and lumbar levels; trigeminal nerves with gasserian ganglia; and sciatic nerves. Tissues were processed for paraffin embedding, sectioned 5 μm thick, stained with haematoxylin and eosin (H&E) and examined by light microscopy. - Statistics:
- The following data in all groups were analysed using multiple comparison tests: body weight, the number of faecal boluses and pools of urine on the open field, the number of grooming episodes and the number of supported or unsupported rearing events in the open field, data from the landing foot spray (cm) and the grip strength (g) for fore- and hindlimbs. They were first analysed by Bartlett’s test. If the group variance was determined to be homogeneous, all groups were compared by a one-way analysis of variance. If Bartlett’s test indicated heterogeneous variance, the Kruskal–Wallis test was employed and Dunnett’s test was used when there was a significant difference between the groups.
Results were expressed as the mean +/- standard deviation (SD). The other categorical and rank data obtained from the detailed clinical observations were analysed by the a × b chi-squared test, and when there was a significant difference Armitage’s chi-squared test was used to compare the difference between each halogenated aniline-treated group and the control group; P < 0.05 or P < 0.01 were considered significant for the statistical tests.
Results and discussion
Effect levels
- Sex:
- male
- Dose descriptor:
- LDLo
- Effect level:
- 600 mg/kg bw
- Based on:
- test mat.
- Mortality:
- None
- Clinical signs:
- other: - cyanosis between days 1 and 4 - only one rat showed decreased movement on day 1 - reduced response to extensor thrust of the hindlimb was found in on days 9 and 15 - gait abnormalities, including ataxia or hindlimb paralysis, were also found on days 9 a
- Other findings:
- Histopathology:
- A spongy change in the white matter of the spinal cords was found
- The lesions arose symmetrically and they were prominent in the lateral and ventral funiculi of the white matter. The lesions in the thoracic level were most prominent throughout the spinal cord. A spongy change in the tegmentum of the mesencephalon or the spinocellebelar tracts of the pons and medulla oblongata, and nerve fibre degeneration in the spinal nerves, trigeminal nerves, or sciatic nerves were also found.
Applicant's summary and conclusion
- Interpretation of results:
- Toxicity Category IV
- Remarks:
- Migrated information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.